MedWatch

Orphazyme share recovers somewhat after dive

After the 30 percent decrease in Orphazyme's share price on Monday, things look somewhat better around noon on Tuesday.

Photo: Orphazyme/PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs